Mark J. Bailey

TL;DR: The vast majority of infected individuals with mild-to-moderate COVID-19 experience robust immunoglobulin G antibody responses against the viral spike protein, and titers are relatively stable for at least a period of about 5 months and that anti-spike binding titers significantly correlate with neutralization of authentic SARS-CoV-2.

TL;DR: It is reported that the vast majority of infected individuals with mild-to-moderate COVID-19 experience robust IgG antibody responses against the viral spike protein, and that anti-spike binding titers significantly correlate with neutralization of authentic SARS-CoV-2.

TL;DR: It is demonstrated that the receptor-binding domain of the HA is required to bind to sialic acid expressed on the surface of effector cells to optimize effector cell activation, and this finding provides a basic understanding of how an optimal antibody-dependent cell-mediated response against influenza virus is achieved and may allow for better vaccine design.

TL;DR: Evidence is provided that broadly neutralizing HA stalk-specific antibodies induce downstream Fc-mediated neutrophil effector functions that will inform the rational design of improved influenza virus vaccines and therapeutics.

TL;DR: In this article, four monoclonal antibodies (mAbs) from an infected patient that target the non-structural protein NS1 were identified and compared to other mAbs.